Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 39
MetricValuePeriodScopeSource row
Operating income−¥831m2025-04-01 → 2025-09-30StandaloneOperating income
Operating income−¥916m2024-04-01 → 2024-09-30StandaloneOperating income
Ordinary income−¥841m2025-04-01 → 2025-09-30StandaloneOrdinary income
Ordinary income−¥1.7bn2024-04-01 → 2025-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥916m2024-04-01 → 2024-09-30StandaloneOrdinary income
Profit before tax−¥841m2025-04-01 → 2025-09-30StandaloneIncome before income taxes
Profit before tax−¥916m2024-04-01 → 2024-09-30StandaloneIncome before income taxes
Net income−¥842m2025-04-01 → 2025-09-30StandaloneProfit loss
Net income−¥1.7bn2024-04-01 → 2025-03-31StandaloneNet income loss (5-year summary)
Net income−¥917m2024-04-01 → 2024-09-30StandaloneProfit loss
Total assets¥509mat 2025-09-30StandaloneAssets
Total assets¥434mat 2025-03-31StandaloneAssets
Total assets¥426mat 2024-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥153mat 2025-09-30StandaloneLiabilities
Total liabilities¥157mat 2025-03-31StandaloneLiabilities
Net assets / equity¥355mat 2025-09-30StandaloneNet assets
Net assets / equity¥278mat 2025-03-31StandaloneNet assets
Net assets / equity¥316mat 2024-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥435mat 2025-09-30StandaloneCash and deposits
Cash and deposits¥339mat 2025-03-31StandaloneCash and deposits
Cash & equivalents¥435mat 2025-09-30StandaloneCash and cash equivalents
Cash & equivalents¥339mat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥349mat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2024-03-31vStandaloneCash and cash equivalents
Operating cash flow−¥811m2025-04-01 → 2025-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.8bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2024-04-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥206,0002024-04-01 → 2025-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥909m2025-04-01 → 2025-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥757m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-77.042025-04-01 → 2025-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-195.582024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-111.442024-04-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio69.4%at 2025-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio63.5%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.9%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued11,525,000at 2025-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued9,729,900at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued8,229,900at 2024-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 321
ItemContextValueUnit
Proceeds from issuance of subscription rights to shares fin cfInterimDuration_NonConsolidatedMember2130000JPY
Net cash provided by used in financing activitiesPrior1InterimDuration_NonConsolidatedMember-JPY
Net cash provided by used in financing activitiesInterimDuration_NonConsolidatedMember909242000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1InterimDuration_NonConsolidatedMember-1112000JPY
Effect of exchange rate change on cash and cash equivalentsInterimDuration_NonConsolidatedMember-1244000JPY
Net increase decrease in cash and cash equivalentsPrior1InterimDuration_NonConsolidatedMember-1067939000JPY
Net increase decrease in cash and cash equivalentsInterimDuration_NonConsolidatedMember96570000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1417062000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember338829000JPY
Cash and cash equivalentsPrior1InterimInstant_NonConsolidatedMember349122000JPY
Cash and cash equivalentsInterimInstant_NonConsolidatedMember435400000JPY
Directors compensations sgaPrior1InterimDuration_NonConsolidatedMember36899000JPY
Directors compensations sgaInterimDuration_NonConsolidatedMember36899000JPY
Taxes and dues cos exp oaPrior1InterimDuration_NonConsolidatedMember27783000JPY
Taxes and dues cos exp oaInterimDuration_NonConsolidatedMember32416000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-11-14
Semi annual accounting period cover pageFilingDateInstant
Original text (Japanese)第16期中(自 2025年4月1日 至 2025年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)Delta-Fly Pharma株式会社
Company name in english cover pageFilingDateInstantDelta-Fly Pharma,Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 江島 淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の5
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088-637-1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 管理部門担当 黒滝 健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町3丁目11番5号日本橋ライフサイエンスビルディング2 6階
Telephone number nearest place of contact cover pageFilingDateInstant03-6231-1278
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 管理部門担当 黒滝 健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE34318
Fund codeFilingDateInstant-
Security codeFilingDateInstant45980
Filer name in japaneseFilingDateInstant
Original text (Japanese)Delta-Fly Pharma株式会社
Filer name in englishFilingDateInstantDelta-Fly Pharma,Inc.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2025-04-01
Current period end dateFilingDateInstant2025-09-30
Type of current periodFilingDateInstantHY
Current fiscal year end dateFilingDateInstant2026-03-31
Previous fiscal year start dateFilingDateInstant2024-04-01
Comparative period end dateFilingDateInstant2024-09-30
Previous fiscal year end dateFilingDateInstant2025-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2025-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2025-09-30pass